Jasper Therapeutics (JSPR) Times Interest Earned (2023 - 2024)
Jasper Therapeutics (JSPR) posted Times Interest Earned of 399.82 for Q2 2024, up 41.64% on a QoQ basis from 685.09 in Q1 2024, and down 144.47% year-over-year from 899.17 in Q3 2023.
Powered by 
Analysis
Jasper Therapeutics (JSPR) Times Interest Earned (2023 - 2024) Analysis & Trends
Jasper Therapeutics has reported Times Interest Earned for 2 years, with the latest figure at 399.82 in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Jasper Therapeutics | 20.11 Mn | 20.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -399.83 |
| Mar 31, 2024 | -685.09 |
| Jun 30, 2023 | -163.55 |
| Mar 31, 2023 | -199.24 |